• Singh, Renu
• Maulik, Pallab K.
• Sagar, Rajesh
• Essue, Beverley M.
• Raman, Usha
• Norton, Robyn
• Peiris, David
• Lempp, Heidi
• Paslawar, Srilatha
• Thornicroft, Graham
• Kallakuri, Sudha
• Yatirajula, Sandhya Kanaka

Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Adolescents are vulnerable to stressors because of the rapid physical and mental changes that they go through during this life period. Young people residing in slum communities experience additional stressors due to living conditions, financial stress, and limited access to healthcare and social support services. The Adolescents’ Resilience and Treatment nEeds for Mental Health in Indian Slums (ARTEMIS) study, is testing an intervention intended to improve mental health outcomes for adolescents living in urban slums in India combining an anti-stigma campaign with a digital health intervention to identify and manage depression, self-harm/suicide risk or other significant emotional complaints.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In the formative phase, we developed tools and processes for the ARTEMIS intervention. The two intervention components (anti-stigma and digital health) were implemented in purposively selected slums from the two study sites of New Delhi and Vijayawada. A mixed methods formative evaluation was undertaken to improve the understanding of site-specific context, assess feasibility and acceptability of the two components and identify required improvements to be made in the intervention. In-depth interviews and focus groups with key stakeholders (adolescents, parents, community health workers, doctors, and peer leaders), along with quantitative data from the digital health platform, were analysed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The anti-stigma campaign methods and materials were found to be acceptable and received overall positive feedback from adolescents. A total of 2752 adolescents were screened using the PHQ9 embedded into a digital application, 133 (4.8%) of whom were identified as at high-risk of depression and/or suicide. 57% (<jats:italic>n</jats:italic> = 75) of those at high risk were diagnosed and treated by primary health care (PHC) doctors, who were guided by an electronic decision support tool based on WHO’s mhGAP algorithm, built into the digital health application.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The formative evaluation of the intervention strategy led to enhanced understanding of the context, acceptability, and feasibility of the intervention. Feedback from stakeholders helped to identify key areas for improvement in the intervention; strategies to improve implementation included engaging with parents, organising health camps in the sites and formation of peer groups.</jats:p></jats:sec><jats:sec><jats:title>Trial Registration</jats:title><jats:p>The trial has been registered in the Clinical Trial Registry India, which is included in the WHO list of Registries, Reference number: CTRI/2022/02/040307. Registered 18 February 2022.</jats:p></jats:sec>

Topics

• impedance spectroscopy
• phase
• size-exclusion chromatography